0001104659-22-096529.txt : 20220831 0001104659-22-096529.hdr.sgml : 20220831 20220831160106 ACCESSION NUMBER: 0001104659-22-096529 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220829 FILED AS OF DATE: 20220831 DATE AS OF CHANGE: 20220831 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lutz Robert Matthew CENTRAL INDEX KEY: 0001786203 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 221217968 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE STREET 2: SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 600 MADISON AVENUE, SUITE 1601 CITY: NEW YORK STATE: NY ZIP: 10022-1737 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 4 1 tm2224840-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-08-29 0 0001420720 iBio, Inc. IBIO 0001786203 Lutz Robert Matthew C/O IBIO, INC., 8800 HSC PARKWAY BRYAN TX 77807 0 1 0 0 See Remark Stock Option (right to buy) 0.28 2022-08-29 4 A 0 400000 0 A 2032-08-28 Common Stock 400000 400000 D These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc. Chief Financial & Business Officer and Principal Accounting Officer /s/Robert Matthew Lutz 2022-08-30